Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin.

Almas Siddiqui, Ingrid Hanson, Julie K Andersen
Author Information
  1. Almas Siddiqui: Buck Institute for Research in Aging, Novato, CA, USA.

Abstract

Increased oxidative stress in the Parkinsonian substantia nigra is believed to contribute to neurodegeneration, in part due to regionally elevated levels of the enzyme monoamine oxidase B (Mao-B). Increased oxidative stress has also been reported to be associated with the inhibition of E3 ligase activity of the Parkinson's disease-related protein parkin. In an inducible Mao-B cell model, losses in parkin E3 ligase activity were found to occur in conjunction with reduced mitochondrial turnover and decreased mitochondrial function, although this did not inhibit parkin's ability to translocation to damaged mitochondria. The mTOR inhibitor rapamycin was found to restore both mitophagy and mitochondrial function in these cells. These data suggest that Mao-B induction can interfere with mitochondrial quality control via losses in parkin activity that in turn impact on mitochondrial turnover. rapamycin may be an effective means of counteracting the effects of lost parkin function by independently enhancing autophagic removal of damaged mitochondria.

References

  1. Hum Mol Genet. 2003 Dec 15;12(24):3231-44 [PMID: 14570716]
  2. Klin Wochenschr. 1991 Dec 15;69(21-23):965-8 [PMID: 1798292]
  3. Hum Mol Genet. 2006 Apr 1;15(7):1209-16 [PMID: 16497721]
  4. Anal Biochem. 1976 May 7;72:248-54 [PMID: 942051]
  5. Lancet Neurol. 2003 Apr;2(4):221-8 [PMID: 12849210]
  6. Neurobiol Dis. 2010 Nov;40(2):444-8 [PMID: 20655384]
  7. Nature. 1997 Aug 28;388(6645):839-40 [PMID: 9278044]
  8. J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72 [PMID: 8786384]
  9. J Biol Chem. 2003 Nov 21;278(47):46432-9 [PMID: 12963742]
  10. Mol Neurobiol. 2004 Aug;30(1):77-89 [PMID: 15247489]
  11. Methods Enzymol. 1996;264:484-509 [PMID: 8965721]
  12. Brain. 2008 Aug;131(Pt 8):1969-78 [PMID: 18187492]
  13. Nature. 1998 Apr 9;392(6676):605-8 [PMID: 9560156]
  14. N Engl J Med. 1983 Aug 4;309(5):310 [PMID: 6602944]
  15. Biochem Soc Trans. 2006 Nov;34(Pt 5):749-53 [PMID: 17052189]
  16. Cell. 2009 Oct 2;139(1):149-60 [PMID: 19804760]
  17. FEBS Lett. 2010 Apr 2;584(7):1386-92 [PMID: 20188730]
  18. Mol Cell. 2010 Oct 22;40(2):280-93 [PMID: 20965422]
  19. J Neurochem. 2007 Dec;103(6):2354-68 [PMID: 17883392]
  20. Science. 2001 Jul 13;293(5528):263-9 [PMID: 11431533]
  21. Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94 [PMID: 17911161]
  22. Mov Disord. 2006 Nov;21(11):1806-23 [PMID: 16972273]
  23. Hum Mol Genet. 2006 Feb 1;15(3):433-42 [PMID: 16368705]
  24. Nat Cell Biol. 2010 Feb;12(2):119-31 [PMID: 20098416]
  25. Nat Neurosci. 2009 Sep;12(9):1129-35 [PMID: 19684592]

Grants

  1. R01 NS045615/NINDS NIH HHS
  2. U54/PHS HHS

MeSH Term

Animals
Autophagy
Cell Differentiation
Cell Survival
Doxycycline
Gene Expression Regulation
Humans
Mitochondria
Monoamine Oxidase
Neurons
Oxidative Stress
PC12 Cells
Protein Transport
Rats
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases
Transfection
Ubiquitin-Protein Ligases
Ubiquitination

Chemicals

Monoamine Oxidase
Ubiquitin-Protein Ligases
parkin protein
MTOR protein, human
TOR Serine-Threonine Kinases
Doxycycline
Sirolimus

Word Cloud

Created with Highcharts 10.0.0mitochondrialparkinMAO-BactivityfunctiondamagedIncreasedoxidativestressE3ligaselossesfoundturnoverparkin'sabilitymitochondriarapamycineffectsParkinsoniansubstantianigrabelievedcontributeneurodegenerationpartdueregionallyelevatedlevelsenzymemonoamineoxidaseBalsoreportedassociatedinhibitionParkinson'sdisease-relatedproteininduciblecellmodeloccurconjunctionreduceddecreasedalthoughinhibittranslocationmTORinhibitorrestoremitophagycellsdatasuggestinductioncaninterferequalitycontrolviaturnimpactRapamycinmayeffectivemeanscounteractinglostindependentlyenhancingautophagicremovalMao-Belevationdecreasesefficientlyclearmitochondria:protective

Similar Articles

Cited By